VITREX MEDICAL A/S: Financial statements 2015
CVR: 14728732
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
VITREX MEDICAL A/S (CVR 14728732) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 21,234,115 and a net result of DKK 6,202,665 compared with DKK 4,611,403 the year before. That is an increase of 32.4% compared with the year before. Equity in the 2015 report amounted to DKK 20,607,335. The solvency ratio was 57.9%.
- Gross Profit
- DKK 21,234,115
- Profit/Loss
- DKK 6,202,665
- Equity
- DKK 20,607,335
- Total Assets
- DKK 35,589,424
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 21.2M | 6.2M | 20.6M | - |
| 2014 | - | 16M | 4.6M | 17.9M | - |
| 2013 | - | 14.7M | 3.9M | 13.3M | - |
Official annual report
How creditworthy is VITREX MEDICAL A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
VITREX MEDICAL A/S has published its interim report for the period May 1, 2014 to December 31, 2014.
About VITREX MEDICAL A/S
VITREX MEDICAL A/S is a Danish company of the type Aktieselskab based in Herlev, founded in 1990. The company is registered under the industry Fremstilling og bearbejdning af andet glas, herunder teknisk glas. The company was previously named MODULOHM A/S and A/S PSE NR. 4106. The management consists of Anders Folkmar Pedersen. The board consists of Michal Staron (chair), Marcin Sieczek and Vagn Andersen. The company is owned by CHIRANA T.Injecta, a. s.. The company has 60 employees (2026). In 2025, the company reported a gross profit of DKK 34,669,165 and a net result of DKK 6,179,533 compared with DKK 1,819,121 the year before. Equity in the 2025 report amounted to DKK 42,246,689.